Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs TRU✓SelectedUSD · TRUGSK vs TRU performance historyLatest closeAs of-2.71%09/08
Stock and ETF performance explorer

GSK vs TRU

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+92.8%
TRU return
+228.6%
Excess return
-135.8%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioTRUExcessAlpha
1D-2.7%-2.8%+0.1%-2.3%
7D-4.2%-7.2%+3.0%-3.1%
30D-7.5%-2.8%-4.7%-7.2%
3M-3.3%+13.0%-16.3%-5.2%
6M-9.3%+0.7%-10.0%-9.8%
YTD+1.6%-9.0%+10.6%+2.1%
1Y+25.5%-16.3%+41.8%+27.5%
3Y+49.3%-1.1%+50.3%+43.7%
5Y+46.7%-36.0%+82.7%+52.9%
10Y+76.8%+139.9%-63.1%+33.3%
All+92.8%+228.6%-135.8%+37.1%

Cumulative growth

Daily Returns

Daily percentage return beside TRU.

Daily Out/Under-Performance

Portfolio return minus TRU return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × TRU return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded TRU wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling